A new age of genetic screening is coming — and we don’t have any rules for it
By Dalton Conley,
The Washington Post
| 06. 14. 2021
New ‘polygenic’ screening techniques open a Pandora’s Box of ethical issues.
After the coronavirus baby bust is over and fertility clinics are booming again, increasing numbers of new parents will bring home a generation of infants prescreened to perform better at school or basketball, resist heart disease or be less likely to have schizophrenia.
It may not be common yet, but the ability to screen embryos for any number of traits is here now, and improving every day. And this brave new world of genetic prediction I’m describing is not just about selecting babies during in vitro fertilization. It could also involve life insurance companies swabbing your cheek before issuing you a policy, preschools and colleges scoring your DNA as part of their admissions process and dating sites asking for your genetic profile before offering you a match.
But with this new technology comes countless ethical questions. Is embryo selection a good thing or a bad thing — or both? How do we balance potential inequities created against potential lives saved or improved? Do we want to keep genetics from becoming destiny, and what does that even mean? We desperately need...
Related Articles
By Dr. Coco Newton, Progress Educational Trust | 03.30.2026
Have you ever wondered what it means to have dozens of half-siblings across the world – or to never know where half of your genetic identity comes from? A recent episode of Zembla explores the human consequences of the global...
By Marcelo Jauregui-Volpe, Wired | 04.24.2026
TWO COMPANIES THAT launched last year with plans to create gene-edited babies have already shut down, citing money issues and internal conflict.
One of them, Manhattan Genomics of New York, closed abruptly shortly after announcing a team of scientific advisers...
By Alexandre Piquard, Le Monde [cites CGS’ Katie Hasson] | 04.27.2026
"Si on en prouve la sûreté, nous croyons que l’édition préventive du génome pourrait être l’une des technologies de santé les plus importantes du siècle. » Lucas Harrington explique ainsi le but de son entreprise Preventive : créer des bébés génétiquement modifiés...
By Abby Vesoulis, Mother Jones | 04.18.2026
Two years ago, we devoted an entire issue to the rise of the American oligarchy. Since then, our oligarchic system has become more entrenched and pervasive, revolving around a small crew of tech titans whose quest for wealth and...